MyAverix Finance
US · Healthcare
Raphael Pharmaceutical Inc. (RAPH)
Drug Manufacturers - Specialty & Generic
Raphael Pharmaceutical Inc. (RAPH) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RAPH
Raphael Pharmaceutical Inc. (RAPH) — FAQ
What is RAPH's P/E ratio?
The price-to-earnings (P/E) ratio for Raphael Pharmaceutical Inc. (RAPH) is 18.00 (data as of 2026-05-23).
Does Raphael Pharmaceutical Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Raphael Pharmaceutical Inc. (RAPH). Check the MyAverix Finance app for the latest dividend data.
What sector is Raphael Pharmaceutical Inc. in?
Raphael Pharmaceutical Inc. (RAPH) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is RAPH listed on?
RAPH is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.